Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb 15;81(4):278-279.
doi: 10.1016/j.biopsych.2016.10.022.

Comparative Transcriptomic Analysis of the Effects of Antidepressant Drugs in Stress-Susceptible Mice

Florian Duclot  1 , Mohamed Kabbaj  2
Affiliations
Comment

Comparative Transcriptomic Analysis of the Effects of Antidepressant Drugs in Stress-Susceptible Mice

Florian Duclot et al. Biol Psychiatry. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures

Drs. Kabbaj and Duclot report no biomedical financial interests or potential conflicts of interest.

Comment on

References

    1. Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: Key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387:1672–1685. - PubMed
    1. Block SG, Nemeroff CB. Emerging antidepressants to treat major depressive disorder. Asian J Psychiatr. 2014;12:7–16. - PubMed
    1. Zarate CA, Jr, Niciu MJ. Ketamine for depression: Evidence, challenges and promise. World Psychiatry. 2015;14:348–350. - PMC - PubMed
    1. Abdallah CG, Averill LA, Krystal JH. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015;1344:66–77. - PMC - PubMed
    1. Reinstatler L, Youssef NA. Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. Drugs R D. 2015;15:37–43. - PMC - PubMed

Publication types

Substances